Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas K Graham

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Cancer|February 21, 2008
Natural killer cell neoplasmsXiayuan Liang, Douglas K Graham
Pediatric Blood & Cancer|February 27, 2008
BAC to the future? comparative genomic hybridization and genotyping pediatric leukemia cytogenetic abnormalitiesDouglas K Graham, Stephen P Hunger
Journal of Cell Signaling|May 29, 2018
The Current State of FLT3 Inhibition in Acute Myeloid Leukemia - Pitfalls and PromisesKatherine A Minson, Deborah DeRyckere, Douglas K Graham
Pediatric Blood & Cancer|April 10, 2007
Precursor natural killer cell leukemiaXiayuan Liang, Brian Greffe, Timothy Garrington, et al.
Cancers|November 27, 2021
Targeting MERTK and AXL in <i>EGFR</i> Mutant Non-Small Cell Lung CancerDan Yan, H Shelton Earp, Deborah DeRyckere, et al.
Expert Opinion on Investigational Drugs|May 25, 2025
Prospects of current AXL-targeting therapies in early phase cancer trialsJuhye Yim, Chloe Hope, Justus M Huelse, et al.
Pediatric Blood & Cancer|September 25, 2004
Successful treatment of severe aplastic anemia in children using standardized immunosuppressive therapy with antithymocyte globulin and cyclosporine ANeil A Goldenberg, Douglas K Graham, Xiayuan Liang, et al.
Critical Reviews in Oncogenesis|December 14, 2011
TAM receptors in leukemia: expression, signaling, and therapeutic implicationsLuis Brandão, Justine Migdall-Wilson, Kristen Eisenman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
Molecular pathways: MERTK signaling in cancerChristopher T Cummings, Deborah Deryckere, H Shelton Earp, et al.
Nature Reviews. Cancer|January 9, 2015
The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancerDouglas K Graham, Deborah DeRyckere, Kurtis D Davies, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Cancer|February 21, 2008
Natural killer cell neoplasmsXiayuan Liang, Douglas K Graham
Pediatric Blood & Cancer|February 27, 2008
BAC to the future? comparative genomic hybridization and genotyping pediatric leukemia cytogenetic abnormalitiesDouglas K Graham, Stephen P Hunger
Journal of Cell Signaling|May 29, 2018
The Current State of FLT3 Inhibition in Acute Myeloid Leukemia - Pitfalls and PromisesKatherine A Minson, Deborah DeRyckere, Douglas K Graham
Pediatric Blood & Cancer|April 10, 2007
Precursor natural killer cell leukemiaXiayuan Liang, Brian Greffe, Timothy Garrington, et al.
Cancers|November 27, 2021
Targeting MERTK and AXL in <i>EGFR</i> Mutant Non-Small Cell Lung CancerDan Yan, H Shelton Earp, Deborah DeRyckere, et al.
Expert Opinion on Investigational Drugs|May 25, 2025
Prospects of current AXL-targeting therapies in early phase cancer trialsJuhye Yim, Chloe Hope, Justus M Huelse, et al.
Pediatric Blood & Cancer|September 25, 2004
Successful treatment of severe aplastic anemia in children using standardized immunosuppressive therapy with antithymocyte globulin and cyclosporine ANeil A Goldenberg, Douglas K Graham, Xiayuan Liang, et al.
Critical Reviews in Oncogenesis|December 14, 2011
TAM receptors in leukemia: expression, signaling, and therapeutic implicationsLuis Brandão, Justine Migdall-Wilson, Kristen Eisenman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
Molecular pathways: MERTK signaling in cancerChristopher T Cummings, Deborah Deryckere, H Shelton Earp, et al.
Nature Reviews. Cancer|January 9, 2015
The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancerDouglas K Graham, Deborah DeRyckere, Kurtis D Davies, et al.
Pageof 9